信息搜索
信息关键字：药
  

共有4382条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220]

·医药行业：增长曲线可能是跃进式2011-9-26 14:08:57
·华海药业：沙坦类增长强劲 制剂出口厚积待发2011-9-26 11:42:09
·华东医药：业绩为主旋律 股改承诺贡献催化剂2011-9-26 11:38:09
·上海证券：4季度医药行业仍有吸引力(名单)2011-9-26 11:17:29
·康芝药业履行社会责任 聚焦儿童慈善事业 2011-9-26 11:04:40
·基金公司明争暗斗竞抢社保百亿弹药2011-9-26 8:09:24
·仟源制药：未来押注在磷霉素氨丁三醇2011-9-26 7:40:05
·众生药业四川大学共研新药2011-9-26 6:54:17
·康芝药业董事长：未来将进军儿童营养品市场2011-9-26 2:26:15
·美国曝药业黑幕25.9美元药物1200美元转卖医院_美洲经济2011-9-25 9:36:02
·康芝药业：设儿童基金力挽形象2011-9-24 9:33:46
·东方证券：维持上海医药“买入”评级2011-9-24 9:04:39
·兼具防御和成长 生物医药“换季”机会显现（附股）2011-9-24 6:50:42
·前7月医药产业销售稳步回升2011-9-24 3:00:45
·战略新兴产业医药专项资金有望年内发放2011-9-24 1:49:41
·复星医药：从青蒿琥酯开始走向世界2011-9-23 15:56:26
·上海医药：抗生素资产如期实现并表2011-9-23 15:35:51
·华海药业：3季度有望保持高增长趋势2011-9-23 15:31:17
·医药生物行业2011年9月第5周周报2011-9-23 15:19:13
·京农公司制药原料被指遭替代 举报人称专利存疑2011-9-23 13:17:56

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220]